Elevated Tacrolimus Blood Concentration Due to the Interaction with Nirmatrelvir/Ritonavir During COVID-19 Treatment: A Case Report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Elevated Tacrolimus Blood Concentration Due to the Interaction with Nirmatrelvir/Ritonavir During COVID-19 Treatment: A Case Report

Published:2023-10 Issue:8 Volume:55 Page:1826-1828
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Cordero Carlos Guzmán^ORCID,de Vicente María Sáez-Torres^ORCID

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference8 articles.

1. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19;Hammond;New Engl J Med,2022

2. Recommendations for the management of drug–drug interactions between the COVID -19 antiviral nirmatrelvir/ritonavir (Paxlovid) and comedications;Marzolini;Clin Pharmacol Ther,2022

3. Determining the time course of CYP3A inhibition by potent reversible and irreversible CYP3A inhibitors using a limited sampling strategy;Katzenmaier;Clin Pharmacol Ther,2011

4. COVID-19 in solid organ transplant recipients: initial report from the US epicenter;Pereira;Am J Transplant,2020

5. Prescribing nirmatrelvir/ritonavir (Paxlovid) for COVID-19 in advanced chronic kidney disease;Hiremath;Clin J Am Soc Nephrol,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormally Elevated Blood Tacrolimus Level Following the Concomitant Use of Nirmatrelvir/Ritonavir With Extended-Release Tacrolimus in a Post-lung Transplant Patient: A Case Report and a Literature Review;Cureus;2024-06-21

2. Case report and literature review: management of Paxlovid (nirmatrelvir/ritonavir)-induced acute tacrolimus toxicity in a patient with systemic lupus erythematosus;Frontiers in Pharmacology;2024-06-19

3. Ritonavir: 25 Years’ Experience of Concomitant Medication Management. A Narrative Review;Infectious Diseases and Therapy;2024-04-12

4. Adaptative Strategy of Immunosuppressive Drugs Dosage Adjustments When Combined With Nirmatrelvir/Ritonavir in Solid Organ Transplant Recipients With COVID-19;Transplant International;2024-03-26

5. Nirmatrelvir+ritonavir/tacrolimus interaction;Reactions Weekly;2023-05-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3